Phase II trial of everolimus monotherapy in the palliative treatment of patients with metastatic transitional cell carcinoma (TCC) after failure of platinum-based therapy: Activity and biomarkers. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results